Ardent Health (NYSE:ARDT - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.30 by $0.22, Zacks reports. The business had revenue of $1.65 billion for the quarter, compared to analysts' expectations of $1.54 billion. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. Ardent Health updated its FY 2025 guidance to 1.730-2.01 EPS.
Ardent Health Trading Up 3.5%
Shares of ARDT stock traded up $0.40 on Friday, reaching $11.87. 497,421 shares of the company's stock were exchanged, compared to its average volume of 540,261. The company's fifty day simple moving average is $12.68 and its 200 day simple moving average is $13.48. Ardent Health has a 52 week low of $10.10 and a 52 week high of $20.72. The company has a current ratio of 2.13, a quick ratio of 1.98 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $1.70 billion and a PE ratio of 6.56.
Institutional Trading of Ardent Health
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Ardent Health by 103.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company's stock worth $194,000 after purchasing an additional 7,182 shares during the period. Creative Planning purchased a new position in shares of Ardent Health during the second quarter valued at $216,000. Acadian Asset Management LLC raised its holdings in shares of Ardent Health by 574.9% in the first quarter. Acadian Asset Management LLC now owns 40,238 shares of the company's stock valued at $550,000 after acquiring an additional 34,276 shares in the last quarter. Jane Street Group LLC raised its holdings in shares of Ardent Health by 235.1% in the first quarter. Jane Street Group LLC now owns 57,468 shares of the company's stock valued at $790,000 after acquiring an additional 40,318 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in Ardent Health by 0.6% in the second quarter. Geode Capital Management LLC now owns 286,848 shares of the company's stock worth $3,918,000 after acquiring an additional 1,769 shares during the period.
Analyst Ratings Changes
ARDT has been the topic of several recent research reports. Stephens reaffirmed an "overweight" rating and set a $21.00 price objective on shares of Ardent Health in a report on Tuesday, May 20th. Wall Street Zen upgraded shares of Ardent Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday. Bank of America lowered shares of Ardent Health from a "neutral" rating to an "underperform" rating and lowered their price objective for the company from $15.50 to $14.60 in a research report on Wednesday, July 16th. Guggenheim lifted their price objective on shares of Ardent Health from $16.00 to $18.00 and gave the stock a "buy" rating in a research note on Friday, May 9th. Finally, Royal Bank Of Canada restated an "outperform" rating and set a $21.00 target price on shares of Ardent Health in a research report on Thursday, May 15th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.97.
Get Our Latest Analysis on ARDT
Ardent Health Company Profile
(
Get Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Featured Articles
Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access